PostEra alternatives and competitors
The closest alternatives to PostEra are Immunai, Chemify, Superluminal Medicines and Iktos.
PostEra is the medicinal chemistry counterpart to the biology platforms that dominate this category. Where Immunai, Cellarity and Enveda build models of cells, tissue or natural product chemistry to decide what to make, PostEra builds models of how to make it.
10 alternatives to PostEra
What each product does, with its price as the vendor publishes it.
-
I
Immunai occupies a different position from most of this category. It is not developing its own drugs.
Price: No published price
-
C
Chemify makes the molecules it designs, in a laboratory it built itself. Rather than handing a design to somebody with a laboratory, it is trying to turn its own laboratory into a printer.
Price: No published price
-
S
Superluminal Medicines chases the same target class as Nabla Bio and Antiverse and attacks it from the opposite direction.
Price: No published price
-
I
Iktos is a Paris generative AI and robotics company for small molecule drug discovery, founded in 2016.
Price: No published price
-
T
Terray Therapeutics is a Los Angeles small molecule company whose founding argument is about data rather than models. Its chief executive Jacob Berlin put it plainly at the Series A: even the most powerful artificial intelligence cannot get past insufficient or unclear data.
Price: Not applicable
-
V
Valo Health uses AI on large scale human data to find drug targets and design small molecules, through its Opal Computational Platform.
Price: No published price
-
D
Deep Genomics is a Toronto AI drug discovery company launched in 2015 by Brendan Frey out of his University of Toronto work on the genetic determinants of disease.
Price: No published price
-
A
Aqemia designs small molecule drug candidates with Qemi, a platform that joins physics based prediction of how tightly a molecule binds its target with generative AI that proposes new molecules.
Price: No published price
-
B
BigHat Biosciences, founded in San Mateo, California in 2019 by Mark DePristo and Peyton Greenside, designs and engineers antibodies with machine learning tied to its own automated laboratory, starting from an existing molecule, its own or a partner's, and improving it in rounds.
Price: No published price
-
R
Recursion (Nasdaq: RXRX) is a Salt Lake City drug discovery company built around the Recursion OS, which pairs automated wet labs running up to 2 million experiments a week with machine learning foundation models trained on the resulting 50 petabyte plus dataset of cellular images…
Price: Not applicable
PostEra alternatives, answered
What are the best alternatives to PostEra?
The closest alternatives to PostEra are Immunai, Chemify, Superluminal Medicines, Iktos and Terray Therapeutics. Immunai occupies a different position from most of this category. Chemify makes the molecules it designs, in a laboratory it built itself. Superluminal Medicines chases the same target class as Nabla Bio and Antiverse and attacks it from the opposite direction.
Who are PostEra's competitors?
PostEra's competitors in the Drug Discovery AI category include Immunai, Chemify, Superluminal Medicines, Iktos, Terray Therapeutics and Valo Health.